Viscoelastic hemostatic assay (VHAs) are whole blood point-of-care tests that have become
an essential method for assaying hemostatic competence in liver transplantation, cardiac …

Viscoelastic-based techniques to evaluate whole blood hemostasis have advanced
substantially since they were first developed over 70 years ago but are still based upon the …

Infection by SARS-CoV-2 is associated with a high risk of thrombosis. The laboratory
documentation of hypercoagulability and impaired fibrinolysis remains a challenge. Our aim …

Viscoelastic testing (VET), including thromboelastography and thromboelastometry,
provides a rapid and comprehensive picture of whole blood coagulation dynamics and …

Viscoelastic hemostatic assays (VHA) are point of care tests that allow for a global
assessment of coagulation using whole blood. The technology to allow this assessment has …

Death due to trauma is the leading cause of lost life years worldwide, with haemorrhage
being responsible for 30-40% of trauma mortality and accounting for almost 50% of the …

Background: Coronavirus Disease 2019 (COVID-19) patients often present with
thromboembolic events. In COVID-19 patients, routine hemostatic assays cannot correctly …

This article explores the application of viscoelastic tests (VETs) in trauma-induced
coagulopathy and trauma resuscitation. We describe the advantages of VETs over …

Patients with coronavirus disease 2019 (COVID-19) frequently experience a coagulopathy
associated with a high incidence of thrombotic events leading to poor outcomes. Here …

2. Dianne K, Jennings I, Kitchen S, Walker I. Letter in response to article “Systematic review
of viscoelastic testing (TEG/Rotem) in obstetrics and recommendations from the women's …